scholarly article | Q13442814 |
P356 | DOI | 10.1002/JCB.25600 |
P698 | PubMed publication ID | 27192488 |
P50 | author | Vincent Sol | Q57562722 |
Youness Limami | Q89368029 | ||
Bertrand Liagre | Q90419811 | ||
Benjamin Rioux | Q92499567 | ||
P2093 | author name string | Mona Diab-Assaf | |
Lama Hassan | |||
Alain Simon | |||
Christelle Pouget | |||
Aline Pinon | |||
Catherine Fagnère | |||
Josiane Semaan | |||
P2860 | cites work | Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis | Q40259853 |
Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells | Q41377344 | ||
Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation | Q43252300 | ||
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis | Q47680928 | ||
The P2Y2/Src/p38/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells. | Q54516019 | ||
HT-29 colorectal cancer cells undergoing apoptosis overexpress COX-2 to delay ursolic acid-induced cell death. | Q54618743 | ||
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing | Q24563789 | ||
Protein kinases and phosphatases in the control of cell fate | Q24604987 | ||
Molecular targeted approaches to cancer therapy and prevention using chalcones | Q27021479 | ||
Global cancer statistics, 2012 | Q27860501 | ||
Control of the G2/M transition | Q28236097 | ||
Genetic alterations during colorectal-tumor development | Q28281200 | ||
Cell-cycle checkpoints and cancer | Q28293996 | ||
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors | Q28297412 | ||
Apoptosis: a review of programmed cell death | Q28305845 | ||
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas | Q29620630 | ||
Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth | Q33925625 | ||
Regulation of the G2/M transition by p53. | Q33943437 | ||
Molecular targets of dietary agents for prevention and therapy of cancer | Q34505253 | ||
A review on plant-derived natural products and their analogs with anti-tumor activity | Q34511478 | ||
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors | Q34624887 | ||
Dietary chalcones with chemopreventive and chemotherapeutic potential | Q34975832 | ||
The role of COX-2 in intestinal inflammation and colorectal cancer | Q35234704 | ||
Apoptosis in cancer: from pathogenesis to treatment | Q35397889 | ||
Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins | Q36323269 | ||
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer | Q36648105 | ||
Current overview of the role of Akt in cancer studies via applied immunohistochemistry | Q37104138 | ||
The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment | Q37366259 | ||
Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs? | Q37437957 | ||
Natural compounds for cancer treatment and prevention | Q37476223 | ||
Autophagy-Mediated Degradation of IAPs and c-FLIP(L) Potentiates Apoptosis Induced by Combination of TRAIL and Chal-24. | Q38829473 | ||
The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer | Q38914271 | ||
Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins. | Q39011086 | ||
The chalcone 2'-hydroxy-4',5'-dimethoxychalcone activates death receptor 5 pathway and leads to apoptosis in human nonsmall cell lung cancer cells. | Q39171821 | ||
Cyclooxygenase-2 positively regulates Akt signalling and enhances survival of erythroleukemia cells exposed to anticancer agents. | Q39189510 | ||
Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade | Q39453587 | ||
Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity | Q39786412 | ||
P433 | issue | 12 | |
P921 | main subject | colorectal cancer | Q188874 |
P304 | page(s) | 2875-2885 | |
P577 | publication date | 2016-05-18 | |
P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
P1476 | title | Resistance to 3-HTMC-Induced Apoptosis Through Activation of PI3K/Akt, MEK/ERK, and p38/COX-2/PGE2 Pathways in Human HT-29 and HCT116 Colorectal Cancer Cells. | |
P478 | volume | 117 |
Q37732985 | Celecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIP. |
Q48274748 | MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5. |
Q55013675 | NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer. |
Q59810238 | Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways |
Search more.